LithiumArgentina_Logo.png
Lithium Argentina Files Meeting Materials to Establish Corporate Domicile in Switzerland
December 11, 2024 16:05 ET | Lithium Americas (Argentina) Corp.
Lithium Argentina files Meeting Materials to Establish Corporate Domicile in Switzerland
Jesper Grankjær Carøe.jpg
Trifork and Swiss Post forge partnership to advance digital transformation of healthcare infrastructure in Switzerland
November 25, 2024 04:30 ET | Trifork Group AG
Press Release Trifork and Swiss Post forge partnership to advance digital transformation of healthcare infrastructure in Switzerland Zürich, Switzerland, November 25, 2024 – Trifork has partnered...
Logo for email.png
Founderful defies European VC consolidation trend with oversubscribed $140m Fund II
November 14, 2024 07:00 ET | Founderful
Zurich, Nov. 14, 2024 (GLOBE NEWSWIRE) -- As Europe’s venture capital market grapples with widespread consolidation and emerging manager buyouts, Founderful has closed an oversubscribed $140 million...
Logo Long.png
Numab Therapeutics Announces Initiation of Phase 1 Clinical Study of NM32 Program in Patients with Solid Tumors
October 30, 2024 08:00 ET | Numab Therapeutics AG
NM32 is a first-in-class half-life-enhanced T-cell engager targeting ROR1, a tumor associated antigen with broad expression in solid tumors and hematological malignancies Low molecular...
Logo-500x500-White-Midnight-Background.jpg
Strong DACH fund manager growth shows region opening up to private capital — Preqin reports
July 17, 2024 02:15 ET | Preqin Ltd
The growth of private markets in Germany, Switzerland and the wider DACH region. Preqin data covering fund manager and assets under management growth.
Logo Long.png
Numab Therapeutics Announces Johnson & Johnson to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for the Treatment of Atopic Dermatitis
May 28, 2024 07:35 ET | Numab Therapeutics AG
Numab Therapeutics Announces J&J to Acquire its Wholly-Owned Subsidiary Yellow Jersey Therapeutics Including Rights to NM26, a Bi-Specific Antibody for AD
Yahoo Logo 1029x579.jpg
Switzerland’s Canton of Ticino Implements BIO-key’s Multi-Factor Authentication Solution in its Information Systems Center
April 09, 2024 09:15 ET | BIO-key International, Inc.
Switzerland’s Canton of Ticino has partnered with Asecus AG to Implement BIO-key’s Multi-Factor Authentication Solution in its Information Systems Center
Screenshot 2023-10-16 at 4.30.56 PM.png
15/2023・Trifork signs strategic investment agreement with Swiss digital health company Bluespace Ventures AG
October 24, 2023 07:53 ET | Trifork Holding AG
Company announcement no. 15 / 2023 Schindellegi, Switzerland – 24 October 2023Trifork signs strategic investment agreement with Swiss digital health company Bluespace Ventures AG As referred to in...
NewGAM_Logo_1.png
NewGAMe investor group welcomes ISS proxy report in favour of all EGM proposals
September 11, 2023 01:00 ET | Newgame SA
Geneva, Sept. 11, 2023 (GLOBE NEWSWIRE) -- NewGAMe investor group welcomes ISS proxy report in favour of all EGM proposals Geneva, 11 September 2023 – The investor group comprised of NewGAMe SA and...
NewGAM_Logo_1.png
The Swiss Takeover Board rules on NewGAMe's partial offer for GAM shares
August 31, 2023 17:17 ET | Newgame SA
Geneva, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The Swiss Takeover Board rules on NewGAMe's partial offer for GAM shares Geneva, 31 August 2023 – The investor group comprised of NewGAMe SA and Bruellan...